 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 1612 | 回復(fù): 6 | ||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | ||
小油2716木蟲 (正式寫手)
|
[求助]
有知道Biomolecules & Therapeutics的格式要求的不?
|
|
老師很忙,沒(méi)空管我,就告訴我投Biomolecules & Therapeutics這個(gè)雜志.想找投稿的格式要求的,突然發(fā)現(xiàn)自己很菜,找不到 只能請(qǐng)有經(jīng)驗(yàn)的童鞋幫忙啦 |
回復(fù)此樓» 猜你喜歡
一志愿北京理工大學(xué)本科211材料工程294求調(diào)劑
已經(jīng)有8人回復(fù)
-
349求調(diào)劑
已經(jīng)有6人回復(fù)
-
329求調(diào)劑
已經(jīng)有9人回復(fù)
-
求調(diào)劑一志愿武漢理工大學(xué)材料工程（085601）
已經(jīng)有9人回復(fù)
-
327求調(diào)劑
已經(jīng)有5人回復(fù)
-
求收留
已經(jīng)有5人回復(fù)
-
375求調(diào)劑
已經(jīng)有4人回復(fù)
-
340求調(diào)劑
已經(jīng)有6人回復(fù)
-
298求調(diào)劑
已經(jīng)有3人回復(fù)
-
085601材料工程找調(diào)劑
已經(jīng)有9人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- 請(qǐng)問(wèn)，cwg格式文件使用什么工具打開的呢?
已經(jīng)有3人回復(fù)
- 求助翻譯一段英文句子
已經(jīng)有2人回復(fù)
- 青基排版格式的-括號(hào)內(nèi)的內(nèi)容刪除了沒(méi)？急啊
已經(jīng)有4人回復(fù)
- 急求數(shù)學(xué)論文摘要翻譯，先謝謝大家了，很短的
已經(jīng)有1人回復(fù)
- 紙質(zhì)材料已經(jīng)，電子版還能改嗎？（只改圖片格式，不改內(nèi)容）
已經(jīng)有10人回復(fù)
- 格式試劑引發(fā)后，變成乳白色粘稠狀，不好攪拌，為什么？
已經(jīng)有4人回復(fù)
- 在windows下如何將.mol2格式的分子導(dǎo)入database數(shù)據(jù)庫(kù)中
已經(jīng)有8人回復(fù)
- 《上帝擲骰子嗎——量子物理史話》精美exe格式電子書版本
已經(jīng)有90人回復(fù)
- cad畫圖后怎么轉(zhuǎn)換成jpg格式？
已經(jīng)有17人回復(fù)
- CTD格式里的S.5對(duì)照品的要求
已經(jīng)有8人回復(fù)
- 國(guó)基申請(qǐng)書中圖片的格式必須用JPG嗎？
已經(jīng)有31人回復(fù)
- 自然基金本子里面的公式圖標(biāo)都轉(zhuǎn)成jpg格式？
已經(jīng)有3人回復(fù)
- 《倪匡全集》典藏版v1.1——史上最全exe格式
已經(jīng)有52人回復(fù)
- 菜鳥求助——著急求助解答：在NCBI上為什么下載不了FASTA格式的基因序列
已經(jīng)有9人回復(fù)
- 國(guó)基格式問(wèn)題求教
已經(jīng)有3人回復(fù)
- polymer therapeutics如何翻譯
已經(jīng)有2人回復(fù)
hailiang1029
金蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 160.2
- 散金: 1219
- 紅花: 5
- 沙發(fā): 3
- 帖子: 990
- 在線: 150.8小時(shí)
- 蟲號(hào): 972066
- 注冊(cè): 2010-03-15
- 專業(yè): 生物化學(xué)
4樓2011-07-19 15:03:42
hailiang1029
金蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 160.2
- 散金: 1219
- 紅花: 5
- 沙發(fā): 3
- 帖子: 990
- 在線: 150.8小時(shí)
- 蟲號(hào): 972066
- 注冊(cè): 2010-03-15
- 專業(yè): 生物化學(xué)
3樓2011-07-19 15:02:09
hailiang1029
金蟲 (正式寫手)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 160.2
- 散金: 1219
- 紅花: 5
- 沙發(fā): 3
- 帖子: 990
- 在線: 150.8小時(shí)
- 蟲號(hào): 972066
- 注冊(cè): 2010-03-15
- 專業(yè): 生物化學(xué)
【答案】應(yīng)助回帖
小油2716(金幣+50): 謝謝啊,我自己看一下~ 2011-07-19 15:07:59
|
Organization of the Manuscript The manuscript must be type written using only Times New Roman font 12 and double-spaced throughout, including references, tables, and figure legends, with at least on 1-inch margins. Manuscripts should contain the following sections, and all pages should be numbered consecutively. 1. Title Page This should contain an article title of less than 150 characters, the authors' names and complete affiliations, and the name and address for manuscript correspondence (including email address and fax number). Note that the title should not contain any nonstandard abbreviations. The corresponding author must confirm that the correspondence address in the manuscript coincides with the address in the cover letter. 2. Running Title A running title, which conveys the sense of the full title, should not exceed 60 characters, including spaces and punctuation. Common abbreviations may be used. 3. Abstract The abstract should succinctly and clearly present the major findings reported in the manuscript. It must not exceed 250 words nor contain abbreviations or specialized terms. After the abstract, a list of up to 6 keywords should be included that will be useful for indexing or searching. 4. Introduction This section should present the purpose of the reported studies and their relationship to earlier work in the field. It should not be an extensive review of the literature nor, in general, exceed two typed pages. 5. Materials and Methods This section should contain explicit, concise descriptions of all new methods or procedures employed. Whereas modifications of previously published methods must be described, commonly used procedures require only a citation of the original source. Descriptions of methods must be sufficiently complete to permit a qualified reader to repeat the reported experiments. The name and location (city, state, and country) of commercial suppliers of chemicals, reagents, and equipment must be given. 6. Results This section contains experimental data, but with no discussion of their signifi cance. Results are typically presented in figures and tables, with no duplication of information in the text. Magnitudes of reported variables should be expressed in numerals. Generally, units are abbreviated without punctuation, and with no distinction between singular and plural forms (e.g., 1 mg, 25 mg). Sufficient data should be presented to allow for judgment concerning the variability and reliability of the results. Statistical probability (p) in tables, figures, and figure legends should be expressed as *p 7. Discussion This section should focus on interpretation of the results, rather than be a repetition of the Results section. It must be as concise as possible and should not exceed four typed pages. 8. Acknowledgments The acknowledgments section should be brief and should precede the references. Personal assistance and financial support are noted here. 9. References References are cited in the text by giving the first author's name (or the fi rst and second if they are the only authors) and the year of publication (e.g. Kim, 1999; Hayaishi and Ueda, 1982; or Ayrton et al., 1991). In the reference list, the references should be arranged alphabetically by author and not numbered. The names of all authors should be given in the reference list. If reference is made to more than one publication by the same author(s) in the same year, suffixes (a, b, c, etc.) should be added to the year in the text citation and in the references list. Abbreviations for journals should conform to the most recent edition of the Chemical Abstracts Service Source Index. The total number of references is limited to 40 except review articles. References to personal communications, unpublished observations, and papers submitted for publication are given in parentheses at the appropriate location in the text, not in the list of references. Only papers that have been officially accepted for publication may be cited as "in press" in the reference list. The authors are responsible for the accuracy of references. The formats for journal articles, chapters, and book references are as follows: Journal article: Ayrton, A. D., Ioannides, C. and Canter, H. V. (1991) Induction of the cytochrome p450 I and IV families and peroxisomal proliferation in the liver of rats treated with benoxaprofen. Biochem. Pharmacol. 42, 109-115. Book reference: Hayaishi, O. and Ueda, K. (1982) ADP-ribosylation reactions, Biology and Medicine. Academic Press., New York. Book chapter: Price, D. and Williams-Ashman, H. G. (1961) The accessory reproductive glands of mammals. In Sex and Internal Secretions (W. C. Young, Ed.), pp. 366-448. Williams & Wilkins, Baltimore. 10. Footnotes Footnotes should be listed on a separate page and used to provide thesis information and citation of meeting abstracts where the work was previously presented, etc. 11. Tables Tables should have titles and sufficient experimental detail in a legend immediately following the title to be understandable without reference to the text. Each column in a table must have a heading, and abbreviations, when necessary, should be defined in the legend. 12. Figures Figures should have titles and explanatory legends containing sufficient details for interpretation. All legends should be printed consecutively in a separate section of the manuscript. All letters in fi gures must be written in the Arial font and be uniform in size and style within each figure. The size of all figures must be prepared the same as appeared in the ultimately published paper (as 1, 1.5, or 2 column-width 87 mm, 120 mm, 178 mm, respectively). Figures should be consecutively numbered using Arabic numerals. Artwork that is supplied electronically must be prepared in high resolution and sent to the Publishing office after acceptance; 1,200 dpi bitmap mode for black and white images such as line graphs, 600 dpi grayscale mode for images such as gels or blots , and 600 dpi CMYK mode for color images. EPS or TIFF fi les are recommended. Powerpoint files are acceptable only when the resolution of images meets the publication quality requirements. Color figures (saved as CMYK files) should be submitted only if reproduction in color is intended. A scale bar should be supplied with photomicrographs. Symbols and abbreviations must be defined in the figure legends. If figure editing is required by the editorial staff for publication in Biomolecules & Therapeutics, charges for figure artwork may be issued to the corresponding authors. 13. Supplemental Data Supplemental data are peer-reviewed materials directly relevant to the conclusion of an article that cannot be included in the printed version. Supplemental data are not subedited, so authors should ensure that it is supplied ready for publication online. Accepted supplemental file formats are Microsoft Office files, movie files (.mov/.mpg), and Acrobat files (.pdf ). 14. Check List (on the Web) If your study is related to a crude extract, you will be asked to submit additional documents by the Editorial office. The required documents may include intellectual property status (patented or patent applied) and/or chemical specification data, such as HPLC or GC chemical profile data, for crude extracts. Ethics The cover letter must state that manuscripts contain original materials, not published and not being considered for publication elsewhere by another journal in whole or in part in any language, including publicly accessible web sites, except as an abstract. Studies involving human subjects and/or parts of human tissues should be performed in accordance with the ethical standards set by the Helsinki Declaration of the World Medical Association in 1964, and revised in 2004. The authors also must certify that animal experiments were conducted in accordance with the guidelines for the Care and Use of Laboratory Animals approved by the authors' institutional review board or responsible governmental administrations. General instructions in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www. icmje.org)' can be applied for the research and publication ethics issues not covered by Biomolecules & Therapeutics Conflict of Interest When a corresponding author submits a manuscript to Biomolecules & Therapeutics, she or he is responsible for disclosing all financial relationships of authors (such as employment, honoraria, consultancies, stock ownership, stock option, etc.) in the manuscript which may bias the work in the manuscript. The corresponding author must complete a Conflict of Interest Disclosure Form on behalf of all authors and submit the form to the editorial office. If a potential conflict of interest is declared, a notification concerning the relationship will be published. The research or project funding/support should be declared in the 'Acknowledgment' section of the manuscript. Editorial Review All manuscripts are subjected to editorial peer review. Upon submission, each manuscript will be quality checked by the editorial office before being sent for review, usually by an Editor and two more referees. The referee's comments and Editor's recommendation will be reviewed by the Editor-in Chief, who will communicate the decision to the author. A paper may be accepted in its original form or accepted subject to revision. The reviewers' suggestions will be conveyed to the corresponding author without identifying the designated editor and reviewers and the author will have an opportunity for revision. If a manuscript returned to an author for revision is held longer than two months, or if revision is sufficiently extensive, the date of receipt of the revised manuscript will be substituted for the initial date of receipt. |
5樓2011-07-19 15:04:56
joyfulnoise
榮譽(yù)版主 (知名作家)
懶人一枚~
- 應(yīng)助: 53 (初中生)
- 貴賓: 2.827
- 金幣: 17467.1
- 散金: 5812
- 紅花: 92
- 沙發(fā): 12
- 帖子: 5030
- 在線: 1278.2小時(shí)
- 蟲號(hào): 449487
- 注冊(cè): 2007-11-02
- 性別: MM
- 專業(yè): 臨床分子生物學(xué)檢驗(yàn)
- 管轄: 教師之家
hailiang10296樓2011-07-19 17:29:52
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 297求調(diào)劑 +10 | 田洪有 2026-03-26 | 10/500 |
|
|---|---|---|---|---|
|
|
[考研]
 一志愿武漢理工，總分321，英一數(shù)二，求老師收留。
+10
|
nnnnnnn5 2026-03-25 | 10/500 |
|
|
|
[考研] 一志愿南航 335分 | 0856 | GPA 4.07 | 有科研經(jīng)歷 +5 | cccchenso 2026-03-29 | 5/250 |
|
|
|
[考研] 332求調(diào)劑 +8 | 蕉蕉123 2026-03-28 | 8/400 |
|
|
[考研] 南京大學(xué)化學(xué)調(diào)劑 +4 | 景隨風(fēng) 2026-03-29 | 7/350 |
|
|
|
[考研] 298求調(diào)劑 +4 | 種圣賜 2026-03-28 | 4/200 |
|
|
|
[考研] 調(diào)劑310 +8 | 溫柔的晚安 2026-03-25 | 9/450 |
|
|
|
[考研] 329求調(diào)劑 +7 | 星野? 2026-03-26 | 7/350 |
|
|
|
[考研] 299求調(diào)劑 +8 | 15188958825 2026-03-25 | 8/400 |
|
|
|
[考研] 0703 化學(xué) 求調(diào)劑，一志愿山東大學(xué) 342 分 +4 | Shern—- 2026-03-28 | 4/200 |
|
|
|
[考研] 311（085601）求調(diào)劑 +4 | liziyeyeye 2026-03-28 | 4/200 |
|
|
|
[考研] 085701環(huán)境工程求調(diào)劑 +9 | 多久上課 2026-03-27 | 9/450 |
|
|
|
[考研] 求調(diào)劑 +4 | 零八# 2026-03-27 | 4/200 |
|
|
|
[考研] 286求調(diào)劑 +4 | lim0922 2026-03-26 | 4/200 |
|
|
|
[考研] 求調(diào)劑，一志愿 南京航空航天大學(xué)大學(xué) ，080500材料科學(xué)與工程學(xué)碩 +4 | @taotao 2026-03-26 | 5/250 |
|
|
|
[考研] 351求調(diào)劑 +4 | 麥克阿磊 2026-03-24 | 4/200 |
|
|
|
[考研] 321求調(diào)劑 +6 | wasdssaa 2026-03-26 | 6/300 |
|
|
|
[考研]
085602 289分求調(diào)劑
+8
|
WWW西西弗斯 2026-03-24 | 8/400 |
|
|
|
[考研] 334分 一志愿武理 材料求調(diào)劑 +4 | 李李不服輸 2026-03-26 | 4/200 |
|
|
|
[考研] 石河子大學(xué)（211、雙一流）碩博研究生長(zhǎng)期招生公告 +3 | 李子目 2026-03-22 | 3/150 |
|